CTOs on the Move

HedgePath Pharmaceuticals

www.hedgepathpharma.com

 
HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. The Company may also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. We are focused on the development of therapies for more than one type of cancer, with initial emphasis in the U.S. market, based upon repurposing the currently marketed antifungal drug itraconazole for new indications in oncology.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

BeVigour

BeVigour is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Prototypes Warn

Prototypes Warn is a Culver City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vermont Gyms d/b/a Synergy Fitness

Vermont Gyms Incorporated d/b/a Synergy Fitness is a Williston, VT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Esoterix Clinical Trial Services

Esoterix Clinical Trial Services is a Cranford, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cohera Medical

Cohera Medical, Inc. is a rapidly growing medical device company actively developing surgical adhesives and sealants. TissuGlu Surgical Adhesive, the first synthetic adhesive approved for internal use, is an easily applied biocompatible, resorbable adhesive that requires no mixing or thawing. Indicated for the approximation of tissue layers where subcutaneous dead space exists between tissue planes in abdominoplasty, TissuGlu Surgical Adhesive has been shown to eliminate the need for postoperative surgical drains in most abdominoplasty procedures.